Biolargo, Inc.
BLGOOTCCIK 880242MaterialsFiscal year ends Dec 31
Reports and events: 239 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-1910:01 ET | DEF 14A | Proxy statementPeriod 2026-12-01 | 0001437749-26-032868 |
| 2026-09-1423:42 ET | 8-K/A | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-030198 |
| 2026-09-1114:38 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-030124 |
| 2026-08-1420:27 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001437749-26-028023 |
| 2026-05-1520:29 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001437749-26-017391 |
| 2026-05-0610:02 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-014996 |
| 2026-05-0411:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-014540 |
| 2026-04-3020:02 ET | 10-K/A | Annual report, amendedPeriod 2025-12-31 | 0001437749-26-014184 |
| 2026-04-0918:50 ET | S-1 | Registration statement | 0001437749-26-011880 |
| 2026-04-0918:35 ET | S-1 | Registration statement | 0001437749-26-011875 |
| 2026-03-2521:06 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001437749-26-009813 |
| 2026-03-0519:31 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-007044 |
| 2026-03-0422:11 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001437749-26-006926 |
| 2025-11-1801:19 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-035506 |
| 2025-11-1422:14 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001437749-25-035239 |
| 2025-11-1421:25 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-035203 |
| 2025-10-2021:12 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-031354 |
| 2025-09-2515:15 ET | 8-K | 1.02 Termination of a material agreement; 2.06 Material impairments; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-029852 |
| 2025-08-1515:50 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-027100 |
| 2025-08-1421:17 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001437749-25-027021 |
| 2025-07-2313:31 ET | 8-K | 7.01 Regulation FD disclosure | 0001437749-25-023293 |
| 2025-06-2521:08 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001437749-25-021276 |
| 2025-05-1521:11 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-017258 |
| 2025-05-1520:30 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001437749-25-017205 |
| 2025-04-2523:09 ET | DEF 14A | Proxy statementPeriod 2025-06-19 | 0001437749-25-013006 |
| 2025-03-3121:29 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-010296 |
| 2025-03-3119:57 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001437749-25-010172 |
| 2024-11-1511:01 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-24-035426 |
| 2024-11-1421:38 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001437749-24-035345 |
| 2024-08-1523:47 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-24-026919 |
| 2024-08-1420:21 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001437749-24-026827 |
| 2024-06-2017:55 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001437749-24-020750 |
| 2024-06-1318:34 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-24-020181 |
| 2024-05-1510:02 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-24-016762 |
| 2024-05-1420:51 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001437749-24-016682 |
| 2024-04-2619:32 ET | DEF 14A | Proxy statementPeriod 2024-06-13 | 0001437749-24-013406 |
| 2024-04-1221:16 ET | S-1 | Registration statement | 0001437749-24-011927 |
| 2024-04-0120:45 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001437749-24-010394 |
| 2024-01-2215:15 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-24-001796 |
| 2024-01-1017:12 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-24-001078 |
| 2024-01-0518:05 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001437749-24-000717 |
| 2023-11-2111:01 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-23-032675 |
| 2023-11-1418:28 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001437749-23-031874 |
| 2023-10-0417:33 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-23-027617 |
| 2023-08-1420:57 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001437749-23-023751 |
| 2023-06-1219:03 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001437749-23-017110 |
| 2023-06-0919:08 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-23-017042 |
| 2023-06-0617:34 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-23-016721 |
| 2023-05-1820:56 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-23-015141 |
| 2023-05-1713:15 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001437749-23-014881 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 14:58 ET. Listed shows no prices and gives no investment advice.